MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$236,990K
Net loss
-$236,928K
Unrealized gain (loss) on
marketable securities
-$62K
Interest income
$8,344K
Net loss before
income taxes
-$236,798K
Provision for income taxes
$130K
Total other income
$4,358K
Interest expense
$3,219K
Other expense, net
-$767K
Loss from operations
-$241,156K
Total operating
expenses
$241,156K
Research and development
$176,065K
General and
administrative
$60,091K
Acquired in-process
research and development
$5,000K
Back
Back
Income Statement
source: myfinsight.com
Neumora Therapeutics, Inc. (NMRA)
Neumora Therapeutics, Inc. (NMRA)